Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8212 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8212 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8079 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8061 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8023 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7947 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7947 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7939 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7907 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7881 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7857 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7853 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7849 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7849 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7811 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7784 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD37 |
Approved |
0.7765 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7759 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7759 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7738 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7738 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7738 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7738 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7738 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7701 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7661 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7627 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7619 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7598 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7578 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7572 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7562 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7558 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7486 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7473 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7472 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7468 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.743 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7429 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7405 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7401 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7389 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7349 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.731 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7296 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7273 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7253 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7253 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7251 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7216 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7212 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7186 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7174 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7168 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7159 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD919 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7108 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7108 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7055 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7051 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7037 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.703 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.6994 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD4663 |
Approved |
0.6989 |
Remote Similarity |
NPD3749 |
Approved |
0.6987 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6982 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6982 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6973 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD2796 |
Approved |
0.697 |
Remote Similarity |
NPD6099 |
Approved |
0.697 |
Remote Similarity |
NPD6100 |
Approved |
0.6961 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6957 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6951 |
Remote Similarity |
NPD4536 |
Approved |
0.6951 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD4538 |
Approved |
0.6944 |
Remote Similarity |
NPD2489 |
Approved |
0.6944 |
Remote Similarity |
NPD27 |
Approved |
0.6941 |
Remote Similarity |
NPD5401 |
Approved |
0.6941 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD7843 |
Approved |
0.6927 |
Remote Similarity |
NPD3051 |
Approved |
0.6927 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6923 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD8156 |
Discontinued |
0.6919 |
Remote Similarity |
NPD4578 |
Approved |
0.6919 |
Remote Similarity |
NPD7310 |
Approved |
0.6919 |
Remote Similarity |
NPD7311 |
Approved |
0.6919 |
Remote Similarity |
NPD4577 |
Approved |
0.6919 |
Remote Similarity |
NPD7312 |
Approved |
0.6919 |
Remote Similarity |
NPD7313 |
Approved |
0.6919 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6909 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6908 |
Remote Similarity |
NPD7157 |
Approved |
0.6905 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6901 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD6273 |
Approved |
0.6894 |
Remote Similarity |
NPD7095 |
Approved |
0.6889 |
Remote Similarity |
NPD2970 |
Approved |
0.6889 |
Remote Similarity |
NPD2969 |
Approved |
0.6882 |
Remote Similarity |
NPD6799 |
Approved |
0.6882 |
Remote Similarity |
NPD7309 |
Approved |
0.6881 |
Remote Similarity |
NPD7047 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD4140 |
Approved |
0.6868 |
Remote Similarity |
NPD8099 |
Discontinued |
0.6868 |
Remote Similarity |
NPD8251 |
Approved |
0.6868 |
Remote Similarity |
NPD8252 |
Approved |
0.6867 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6867 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6867 |
Remote Similarity |
NPD228 |
Approved |
0.6862 |
Remote Similarity |
NPD6842 |
Approved |
0.6862 |
Remote Similarity |
NPD6841 |
Approved |
0.6862 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6842 |
Remote Similarity |
NPD2532 |
Approved |
0.6842 |
Remote Similarity |
NPD2534 |
Approved |
0.6842 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD2533 |
Approved |
0.6839 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6835 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6829 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6826 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6826 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6826 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6826 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6815 |
Remote Similarity |
NPD3705 |
Approved |
0.6815 |
Remote Similarity |
NPD1091 |
Approved |
0.681 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6807
|
Remote Similarity |
NPD5960 |
Phase 3 |